Marinomed Biotech AG (MARI.VI)
EUR 12.2
(-6.15%)
EUR 12.2
(-6.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.61 Million EUR | -34.44% |
| 2022 | 22.28 Million EUR | 4.45% |
| 2021 | 21.33 Million EUR | -9.21% |
| 2020 | 23.5 Million EUR | 20.51% |
| 2019 | 19.5 Million EUR | 270.51% |
| 2018 | 5.26 Million EUR | -43.58% |
| 2017 | 9.32 Million EUR | 89.46% |
| 2016 | 4.92 Million EUR | -20.26% |
| 2015 | 6.17 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.14 Million EUR | -16.86% |
| 2023 Q4 | 14.61 Million EUR | -3.69% |
| 2023 Q2 | 17.83 Million EUR | -8.42% |
| 2023 Q3 | 15.17 Million EUR | -14.93% |
| 2023 Q1 | 19.47 Million EUR | -12.62% |
| 2023 FY | 14.61 Million EUR | -34.44% |
| 2022 FY | 22.28 Million EUR | 4.45% |
| 2022 Q4 | 22.28 Million EUR | -6.09% |
| 2022 Q3 | 23.73 Million EUR | -5.35% |
| 2022 Q2 | 25.07 Million EUR | -2.81% |
| 2022 Q1 | 25.79 Million EUR | 20.91% |
| 2021 FY | 21.33 Million EUR | -9.21% |
| 2021 Q2 | 18.39 Million EUR | -12.53% |
| 2021 Q4 | 21.33 Million EUR | 20.15% |
| 2021 Q3 | 17.75 Million EUR | -3.48% |
| 2021 Q1 | 21.03 Million EUR | -10.5% |
| 2020 Q3 | 17.5 Million EUR | -1.98% |
| 2020 Q2 | 17.86 Million EUR | -1.56% |
| 2020 Q1 | 18.14 Million EUR | -6.97% |
| 2020 FY | 23.5 Million EUR | 20.51% |
| 2020 Q4 | 23.5 Million EUR | 34.24% |
| 2019 FY | 19.5 Million EUR | 270.51% |
| 2019 Q4 | 19.5 Million EUR | 23.68% |
| 2019 Q3 | 15.76 Million EUR | 1.31% |
| 2019 Q2 | 15.56 Million EUR | -25.64% |
| 2019 Q1 | 20.93 Million EUR | 297.67% |
| 2018 Q4 | 5.26 Million EUR | -19.23% |
| 2018 FY | 5.26 Million EUR | -43.58% |
| 2018 Q3 | 6.51 Million EUR | 0.0% |
| 2017 Q4 | 9.32 Million EUR | 0.0% |
| 2017 FY | 9.32 Million EUR | 89.46% |
| 2016 FY | 4.92 Million EUR | -20.26% |
| 2015 FY | 6.17 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|